Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 6, Pages 1368-1382Publisher
WILEY-BLACKWELL
DOI: 10.1002/ijc.27797
Keywords
pancreatic cancer; formalin-fixed paraffin-embedded (FFPE); laser microdissection (LMD); liquid chromatography-tandem mass spectrometry (LC-MS; MS); scheduled selected reaction monitoring (sSRM)
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [19689028, 22390254]
- Kurokawa Cancer Research Foundation
- Grants-in-Aid for Scientific Research [19689028, 22390253, 22390254] Funding Source: KAKEN
Ask authors/readers for more resources
Pancreatic cancer is among the most lethal malignancies worldwide. We aimed to identify novel prognostic markers by applying mass spectrometry (MS)-based proteomic analysis to formalin-fixed paraffin-embedded (FFPE) tissues. Resectable, node positive pancreatic ductal adenocarcinoma (PDAC) with poor (n = 4) and better (n = 4) outcomes, based on survival duration, with essentially the same clinicopathological backgrounds, and noncancerous pancreatic ducts (n = 5) were analyzed. Cancerous and noncancerous cells collected from FFPE tissue sections by laser microdissection (LMD) were processed for liquid chromatography (LC)-tandem MS (MS/MS). Candidate proteins were identified by semiquantitative comparison and then analyzed quantitatively using selected reaction monitoring (SRM)-based MS. To confirm the associations between candidate proteins and outcomes, we immunohistochemically analyzed a cohort of 87 cases. In result, totally 1,229 proteins were identified and 170 were selected as candidate proteins for SRM-based targeted proteomics. Fourteen proteins overexpressed in cancerous as compared to noncancerous tissue showed different expressions in the poor and better outcome groups. Among these proteins, we found that three novel proteins ECH1, OLFM4 and STML2 were overexpressed in poor group than in better group, and that one known protein GTR1 was expressed reciprocally. KaplanMeier analysis showed high expressions of all four proteins to correlate with significantly worse overall survival (p < 0.05). In conclusion, we identified four proteins as candidates of prognostic marker of PDAC. The combination of shotgun proteomics verified by SRM and validated by immunohistochemistry resulted in the prognostic marker discovery that will contribute the understanding of PDAC biology and therapeutic development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available